Short communication: Effect of commercial or depurinized milk diet on plasma advanced oxidation protein products, cardiovascular markers, and bone marrow CD34+ stem cell potential in rat experimental hyperuricemia

Journal of Dairy Science

Volumn 97, Issue 11, 2014, Pages 6823-6827

  Kocic, Gordana ^a   Sokolovic, Dusan ^a   Jevtovic, Tatjana ^a   Cvetkovic, Tatjana ^a   Veljkovic, Andrej ^a   Kocic, Hristina ^b   Stojanovic, Svetlana ^a   Jovanovic, Aneta ^c   Jovanovic, Jelena ^c   Zivkovic, Petar ^c  

^a Ni University Medical Faculty   (Serbia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

^c UNIVERSITY OF NI   (Serbia)

Author keywords

Advanced oxidation protein products (AOPP); Bone marrow CD34+; Cardiovascular marker; Hyperuricemia; Milk

Indexed keywords

RATTUS;

ADVANCED OXIDATION PROTEIN PRODUCT; ALLOPURINOL; BIOLOGICAL MARKER; CD34 ANTIGEN; HIGH DENSITY LIPOPROTEIN; PURINE; PURINE DERIVATIVE; URIC ACID;

ANIMAL; BLOOD; BONE MARROW; CHEMISTRY; DIET THERAPY; DISEASE MODEL; HYPERURICEMIA; METABOLISM; MILK; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; RAT; STEM CELL;

ADVANCED OXIDATION PROTEIN PRODUCTS; ALLOPURINOL; ANIMALS; ANTIGENS, CD34; BIOLOGICAL MARKERS; BONE MARROW; DISEASE MODELS, ANIMAL; HYPERURICEMIA; LIPOPROTEINS, HDL; MILK; OXIDATIVE STRESS; PURINES; RATS; STEM CELLS; URIC ACID;

EID: 84908354217     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2014-8556     Document Type: Article

References (24)

1. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Leri A., Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705. http://dx.doi.org/10.1038/35070587.
2. Carluccio, F., and G. Kocic. 2011. Procedimento technologico per de la producone di un alimentare dietetico composito a base di latte con livello ridoto di acido urico e purine e prodoto alimentare cosi ottenuto. F. Carluccio and G. Kocic, assignees. Italy patent no. IT2009PR00057 20090723.
3. Cencic, A., G. Kocic, G. Nikolic, D. Stojanovic, R. Pavlovic, T. Jevtovic-Stoimenov, D. Sokolovic, S. Stojanovic, S. Pajovic, R. Kocic, F. Carluccio, I. Krajnc, and A. Murua. 2011. Composite dietetic milk draught and method for production of composite milk draught with reduced level of uric acid and purine compounds. A. Cencic, assignee. Slovenia patent no. WO2011037545 (A1) 2011-03-31.
4. Cheng T.H., Lin J.W., Chao H.H., Chen Y.L., Chen C.H., Chan P., Liu J.C. Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts. Int. J. Cardiol. 2010, 139:42-49.
5. Corry D.B., Eslami P., Yamamoto K., Nyby M.D., Makino H., Tuck M.L. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J. Hypertens. 2008, 26:269-275.
6. Dalbeth N.S., Greg D., Gamble G.D.A., Mason B., Pool B., Fairbanks L., McQueen F.M., Cornish J., Reid I.R., Palmano K. Acute effect of milk on serum urate concentrations: A randomised controlled crossover trial. Ann. Rheum. Dis. 2010, 69:1677-1682.
7. Dunkelgrun M., Welten G.M., Goei D., Winkel T.A., Schouten O., van Domburg R.T., van Gestel Y.R., Flu W.J., Hoeks S.E., Bax J.J., Poldermans D. Association between serum uric acid and perioperative and late cardiovascular outcome in patients with suspected or definite coronary artery disease undergoing elective vascular surgery. Am. J. Cardiol. 2008, 102:797-801.
8. Enomoto A., Kimura H., Chairoungdua A., Shigeta Y., Jutabha P., Cha S.H., Hosoyamada M., Takeda M., Sekine T., Igarashi T., Matsuo H., Kikuchi Y., Oda T., Ichida K., Hosoya T., Shimokata K., Niwa T., Kanai Y., Endou H. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002, 417:447-452.
9. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic follow-up study, 1971-1992. JAMA 2000, 283:2404-2410.
10. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. N. Engl. J. Med. 2008, 359:1811-1821.
11. Foell D., Wittkowski H., Roth J. Mechanisms of disease: A 'DAMP' view of inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 2007, 3:382-390.
12. Hayden M.R., Tyagi S.C. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr. Metab. (Lond.) 2004, 1:10.
13. Ioachimescu A.G., Brennan D.M., Hoar B.M., Hazen S.L., Hoogwerf B.J. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum. 2008, 58:623-630.
14. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., Entman M.L., Michael L.H., Hirschi K.K., Goodell M.A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 2001, 107:1395-1402.
15. Kocic, G., L. Marinkovic, S. Stojanovic, G. Nikolic, and D. Stojanovic. 2011. Adsorption filter device for production of depurinised milk. G. Kocic, assignee. Serbia patent no. RS20100157 (A) 2011-04-30.
16. Kocic, G., G. Nikolic, D. Stojanovic, R. Pavlovic, T. Jevtovic-Stoimenov, D. Sokolovic, S. Stojanovic, S. Pajovic, and R. Kocic. 2010Technological procedure for production of composite dietetic milk beverage draught with reduced level of uric acid and purine. G. Kocic, assignee. Serbia patent no. RS20090231 (A) 2010-12-31.
17. Kocic G., Pavlovic R., Nikolic G., Stojanovic D., Jevtovic T., Sokolovic D., Cencic A., Stojanovic S., Jelic M., Zivanovic S. The effect of depurinized milk draught diet on rat serum uric acid, lipid status and haematological parameters. J. Anim. Physiol. Anim. Nutr. (Berl.) 2012, 96:640-647.
18. Kocic G., Pavlovic R., Nikolic G., Veljkovic A., Panseri S., Chiesa L.M., Andjelkovic T., Jevtovic-Stoimenov T., Sokolovic D., Cvetkovic T., Stojanovic S., Kocic H., Nikolic R. Effect of commercial or depurinized milk on rat liver growth-regulatory kinases, nuclear factor-kappa B, and endonuclease in experimental hyperuricemia: Comparison with allopurinol therapy. J. Dairy Sci. 2014, 97:4029-4042.
19. Marsche G., Frank S., Hrzenjak A., Holzer M., Dirnberger S., Wadsack C., Scharnagl H., Stojakovic T., Heinemann A., Oettl K. Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ. Res. 2009, 104:750-757.
20. Orlic D., Hill J.M., Arial A.E. Stem cells for myocardial regeneration. Circ. Res. 2002, 91:1092-1102.
21. Patschan D., Patschan S., Gobe G., Chintal S., Goligorsky M.S. Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor. J. Am. Soc. Nephrol. 2007, 18:1516-1524.
22. Strasak A.M., Kelleher C.C., Brant L.J., Rapp K., Ruttmann E., Concin H., Diem G., Pfeiffer K.P., Ulmer H. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study. Int. J. Cardiol. 2008, 125:232-239.
23. Tavil Y., Kaya M.G., Oktar S.O., Sen N., Okyay K., Yazici H.U., Cengel A. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis 2008, 197:159-163.
24. Yagi K. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol. Biol. 1998, 108:107-110.